Tag: Evusheld
The Evusheld is no longer indicated against the Covid, why?
Developed by AstraZeneca, the Evusheld treatment (tixagevimab and cilgavimab) with monoclonal antibodies against Covid-19 is no longer indicated, informs the DGS in January 2023. Summary The treatment Evusheld against Covid-19…
Covid-19 treatment: HAS expands access to Evusheld® for immunocompromised people over 12 years old
News Posted 1 day ago, Reading 2 mins. Immunocompromised people are more vulnerable to Covid-19, more at risk of developing a severe form of the disease. Since March 18, the…
Covid-19: some ineffective treatments against Omicron
News Posted the 01/06/2022 at 11:35 am, 2 min read The ANSM has decided to limit the use of certain curative and prophylactic drugs against Covid-19 to infections by the…